Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photo Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113248422A details a visible-light catalyzed method for chiral azaarenes, offering green synthesis and high enantioselectivity for pharmaceutical intermediates.
Novel photocatalytic route for dihydronaphthalene derivatives offering mild conditions and high yields for pharmaceutical intermediates.
Patent CN112898202A details a mild visible-light photocatalytic method for synthesizing heterocyclyl cyclopropane compounds, offering significant advantages for pharmaceutical intermediate manufacturing.
Novel visible-light catalytic ruthenium complex enables efficient alkyne-aldehyde addition. Reduces energy costs and simplifies purification for pharmaceutical intermediate manufacturing.
Novel metal-free visible light catalytic method for 1,2,3,4-tetrahydronaphthalene intermediates. Offers high atom utilization and mild conditions for pharma manufacturing.
Patent CN117247370A enables room-temperature thioflavonoid synthesis using CO2. Offers cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN114874139A details a green visible-light method for synthesizing dihydroisoquinoline intermediates, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Novel photocatalytic method for cyanosulfonyl fluoride compounds offers efficient synthesis and supply chain advantages for pharmaceutical intermediates manufacturing globally.
Patent CN108299296A details a visible-light induced synthesis of phenanthridine derivatives using organic photocatalysts, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN114213254B details a visible-light mediated synthesis of beta-nitroketones. Offers high yield, mild conditions, and scalable routes for pharmaceutical intermediates.
Patent CN111072605B details a visible-light catalyzed method for fluoroalkyl-substituted benzofurans. Offers mild conditions and high yields for pharma intermediates.
Patent CN117003678B reveals green iodide-catalyzed route for naphthylamine derivatives. Offers significant cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally without transition metals.
Patent CN117164492B enables metal-free synthesis of high-purity vinyl selenone compounds. Achieve cost reduction and supply reliability in pharmaceutical intermediate manufacturing.
Patent CN110540516B details a mild visible-light protocol for dihydronaphthalenes, offering cost-effective routes for pharmaceutical intermediates.
Patent CN110540516B reveals visible-light mediated synthesis of dihydronaphthalenes. High yield, mild conditions, reliable pharmaceutical intermediate supplier.
Patent CN117164492B details metal-free photocatalytic synthesis. Offers high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.
Novel ruthenium-catalyzed route for E-configuration monofluoro alkenyl silicon. Reduces steps and cost for pharmaceutical intermediates manufacturing.
Patent CN114805209B details a metal-free photocatalytic route for 3-aryl-2H-indazoles, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel Rose Bengal catalyzed method for alpha-indole glycine derivatives offers green, scalable production for pharmaceutical intermediates.
Patent CN111892545A reveals a green photocatalytic route for quinoxalinones. Achieve high yields without transition metals, ensuring cost reduction in API manufacturing and reliable supply.